DENUB 60MG INJECTION

Denub 60mg injection contains the active ingredient Denosumab. It is a drug for treating osteoporosis, which is characterized by weak bones. It’s also used to reduce the risk of bone-related complications in patients suffering from certain types of cancer, including bone metastases and multiple myeloma. Denub 60 mg Injection works by blocking a protein known as RANK Ligand, which is responsible for the destruction of the bone. Research has shown that it can increase bone density while also decreasing the risk of fractures in postmenopausal females who have osteoporosis or cancer-related loss of bone. Monitoring of renal function closely is recommended for patients suffering from moderate impairment in their renal function.
Denub 60mg injection should not be administered to individuals who have known allergies or hypersensitivity to its constituents. The proper intake of vitamin D and calcium intake is necessary to maintain the treatment. It is not recommended for use in children and adolescents. The safety and efficacy of this medication in children have not been proven. Therefore, its use is not recommended for people under the age of 18. This medication should be taken cautiously for patients who have hypoparathyroidism, which is defined by low levels of parathyroid hormone.